Home › NDC Lookup › RxCUI directory › RxCUI 2602306

Tapinarof 10 MG/ML Topical Cream [Vtama] — RxCUI 2602306

RxNorm drug concept · Semantic branded drug
RxCUI 2602306 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2602306
Official nameTapinarof 10 MG/ML Topical Cream [Vtama]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVtama 10 MG/ML Topical Cream; Vtama 1 % Topical Cream
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)31,509 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tapinarof Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Vtama cream treats plaque psoriasis in adults. It also treats atopic dermatitis, or eczema, in adults and children 2 and older.
  • Put a thin layer on the affected skin once a day. Wash your hands afterward unless you are treating your hands. Keep it out of your mouth, eyes and vagina.
  • The most common is folliculitis, which is irritated hair follicles. Some people get skin rash, itching, headache or cold-like symptoms. Let your doctor know if a rash or skin react...
  • For atopic dermatitis, yes, in children 2 and older. It has not been shown to be safe and effective for psoriasis in children, or for eczema under age 2.
📖 Read our full Tapinarof Topical guide →

🕸️ Concept Web — How Tapinarof 10 MG/ML Topical Cream [Vtama] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tapinarof 10 MG/ML Topical Cream [Vtama] RxCUI 2602306

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tapinarof 2602286
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vtama 2602302
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tapinarof Topical Cream 2602300
    • Tapinarof Topical Product 2602299
    • Tapinarof Topical Cream [Vtama] 2602305
    • Vtama Topical Product 2602304
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tapinarof 10 MG/ML Topical Cream SCD · 2602301
  • Tapinarof 10 MG/ML SCDC · 2602298
  • Tapinarof Topical Cream SCDF · 2602300
  • Tapinarof Topical Product SCDG · 2602299

Brand-Name Concepts

  • Tapinarof 10 MG/ML [Vtama] SBDC · 2602303
  • Tapinarof Topical Cream [Vtama] SBDF · 2602305
  • Vtama Topical Product SBDG · 2602304
  • Vtama BN · 2602302

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2602306 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81672-5051-01 1 TUBE in 1 PACKAGE (81672-5051-1) / 60 g in 1 TUBE VTAMA Organon LLC 2025-05-28
Observed labelers: Organon LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$25.2497
Range $25.2497–$25.2497 · middle 50% $25.2497–$25.2497 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.